Diabetic maculopathy;Die diabetische makulopathie

Ophthalmologe

Volumn 98, Issue 9, 2001, Pages 908-919

  Joussen, A M ^a   Lemmen, K D ^b   Kirchhof, B ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b St Martinus Krankenhaus Dusseldorf   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ACETYLSALICYLIC ACID; CARBONATE DEHYDRATASE INHIBITOR; DOBESILATE CALCIUM;

CILIARY DISK; DIABETES MELLITUS; LASER SURGERY; RETINA MACULA EDEMA; RETINA MACULOPATHY; REVIEW; RISK FACTOR; VITRECTOMY; CAPILLARY PERMEABILITY; DIABETIC RETINOPATHY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA BLOOD VESSEL; RETINA MACULA CYSTOID EDEMA;

CAPILLARY PERMEABILITY; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; MACULAR EDEMA, CYSTOID; MALE; RETINAL VESSELS; RISK FACTORS;

EID: 18044403188     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003470170073     Document Type: Review

References (69)

1. Photocoagulation for diabetic macular edema. ETDRS Report No. 1
2. Photocoagulation for diabetic macular edema, ETDRS report No. 4
3. Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline. ETDRS Report No. 19
4. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy
5. Photocoagulation for diabetic macular edema
6. Diabetic retinopathy in Joslin Clinic patients with adult onset diabetes
7. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
8. The pathogenesis of edema in diabetic maculopathy
9. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: Vascular endothelial growth factor decreases occludin in retinal endothelial cells
10. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes
11. Calcium dobesilate: Pharmacological profile related to its use in diabetic retinopathy
12. Leitlinie Nr. 20: "Diabetische retinopathie"
13. Calcium dobesilate versus placebo in the treatment of diabetic retinopathy: A double-blind cross-over study
14. Loss of tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood-brain barrier breakdown in vivo
15. Acute modulation of albumin microvascular leakage by advanced glycation end products in microcirculation of diabetic rats in vivo
16. Diabetic macular edema. A review
17. Vitreous fluorimetric evaluation of diabetics
18. Prevention of retinal capillary basement membrane thickening in diabetic rats by aldose reductase inhibitors
19. The active transport of fluorescein by the retinal vessel and the retina
20. Polymorphonuclear leukocyte adhesion triggers the disorganization of endothelial cell-to-cell adherens junctions
21. Longterm follow-up of medical conditions in patients with diabetic exsudative maculopathy
22. Blood-retinal barrier permeability and its relation to progression of diabetic retinopathy in type 1 diabetes. An 8 year follow-up study
23. Macular Edema. A complication of diabetic retinopathy
24. Subretinal fibrosis in diabetic macular edema. ETDRS report 23
25. Microvascular protection with calcium dobesilate (Doxium) in diabetic retinopathy
26. Resolution of diabetic macular edema after surgical removal of posterior hyaloid and the inner limiting membrane
27. Indocyanine green selectively stains the internal limiting membrane
28. Histophathology of diabetic retinopathy
29. Retinal function in diabetic macular edema after focal laser photocoagulation
30. The nature and extent of retinal dysfunction associated with diabetic macular edema
31. Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product Nepsilon-(carboxy-methyl) lysine independently of glycohaemoglobin concentrations
32. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
33. Leukocyte-mediated endothelial cell injury and death in the diabetic retina
34. Perifoveal microcirculation before and after vitrectomy for diabetic cystoid macular edema
35. Visual impairment in diabetes
36. The Wisconsin Epidemiologic Study of diabetic Retinopathy IV. Diabetic macular edema
37. The Wisconsin Epidemiologic Study of Diabetic Retinopathy IX. The incidence of diabetic macular edema
38. Screening and prevention of blindness
39. The blood retinal barrier permeability in diabetic patients
40. Long term effects of modified grid laser photocoagulation for diffuse macular edema
41. Photocoagulation of diabetic macular oedema - Complications and visual outcome
42. The effect on the macular function of laser photocoagulation for diabetic macular edema
43. Vascular endothelial growth factor-induced retinal vascular permeability is nediated by intercellular adhesion molecule-1 (ICAM-1)
44. Prevention of leukostasis and vascular leakage in streptozotocin- induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition
45. The incidence of visual loss in a diabetic population
46. Immunohistochemical detection of blood-retinal barrier breakdown in streptozotocin-diabetic rats
47. Argon-green (514 nm) vs kryptn-red (647 nm) modified grid laser photocoagulation for diffuse diabetic macular edema
48. Modified grid argon (blue-green) laser photocoagulation for diffuse diabetic macular edema
49. Retinal blood flow in diabetic retinopathy
50. Early diabetic blood-retinal barrier breakdown in VEGF-dependent
51. Diabetic macular edema: Passive and active transport of fluorescein through the blood-retinal barrier
52. Studies on the permeability of the blood-retinal barrier. IV: Junctional complexes of the retinal vessels and their role in the permeability of the blood-retinal barrier
53. Advanced glycation end products induce blood-retinal barrier dysfunction in normoglycemic rats
54. Modified grid laser photocoagulation for diabetic macular edema: The effect on the central visual field
55. Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy: A randomized controlled clinical trial
56. Effects of haemodialysis on diabetic macular leakage
57. Electron microscopic evidence for the mechanism of blood-retinal barrier breakdown in diabetic rabbits: Comparison with magnetic resonance imaging
58. Cellular mechanisms of blood-retinal barrier dysfunction in macular edema
59. Ultrastructural localization of blood-retinal barrier breakdown in diabetic and galacosemic rats
60. Clinically significant macular edema in type 1 diabetes
61. Optical cross-sectional observation of resolved diabetic macular edema associated with vitreomacular separation
62. Non-retinovascular leakage in diabetic maculopathy
63. Improvement of visual acuity in patients suffering from diabetic retinopathy after membrane differential filtration: A pilot study
64. Outward permeability of the blood-retinal barrier